Exelixis recently advanced its oncology pipeline by submitting an FDA application for its next-generation cancer drug zanzalintinib, in combination with Roche’s Tecentriq, for metastatic colorectal ...
How to catch that falling knife — a look at the iShares Expanded Tech-Software Sector ETF (IGV) . Here's the quick answer: You don't. When you see an ETF or a stock make a dramatic move to the ...
The selloff, partly sparked by AI developer Anthropic's updated chatbot release last week that heightened fears of AI-driven disruption in the data and professional services industry, broadened on ...
YOU’RE WATCHING KOAT ACTION SEVEN NEWS. A NEIGHBORHOOD IN FEAR. RANDOM PEOPLE WANDERING THROUGH A PREVIOUSLY QUIET NEIGHBORHOOD THAT SAW AN INCREASE IN CRIMES. TONIGHT, IN A TARGET 7 INVESTIGATION, ...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Why Exelixis Stock Is On Investors’ Radar Today Exelixis ...
New tools by artificial intelligence companies like Anthropic have reignited worries that businesses will pare down their subscriptions to software services. By Andrew Ross Sorkin Bernhard Warner ...
Amanda Smith is a freelance journalist and writer. She reports on culture, society, human interest and technology. Her stories hold a mirror to society, reflecting both its malaise and its beauty.
Agents use facial recognition, social media monitoring and other tech tools not only to identify undocumented immigrants but also to track protesters, current and former officials said. By Sheera ...
ZDNET experts put every product through rigorous testing and research to curate the best options for you. If you buy through our links, we may earn a commission. Learn Our Process 'ZDNET Recommends': ...
Learn to calculate fixed asset depreciation in Excel using methods like straight-line, sum of the years' digits, and more for accurate financial analysis.
Master R-Squared calculation in Excel. Get formula tips, expert advice, and avoid errors for precise financial analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results